Seth Blackley - 03 Mar 2023 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role
Chief Executive Officer, Director
Signature
/s/ Jonathan Weinberg, Attorney-in-fact
Issuer symbol
EVH
Transactions as of
03 Mar 2023
Net transactions value
-$5,835,155
Form type
4
Filing time
07 Mar 2023, 17:06:34 UTC
Previous filing
03 Mar 2023
Next filing
20 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Options Exercise $0 +360,000 +61% $0.000000 951,994 03 Mar 2023 Direct F1, F2
transaction EVH Class A Common Stock Sale $2,473,910 -71,916 -7.6% $34.40 880,078 06 Mar 2023 Direct F2, F3, F4
transaction EVH Class A Common Stock Sale $70,440 -2,012 -0.23% $35.01 878,066 06 Mar 2023 Direct F2, F3, F5
transaction EVH Class A Common Stock Sale $3,290,804 -95,055 -11% $34.62 783,011 07 Mar 2023 Direct F2, F3, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVH Leveraged Restricted Stock Unit Options Exercise $0 -360,000 -100% $0.000000* 0 03 Mar 2023 Class A Common Stock 360,000 $0.000000 Direct F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the vesting of the leveraged stock units ("LSUs") granted to Mr. Blackley on March 2, 2020, based on the cumulative performance of the Issuer's Class A Common Stock.
F2 Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F3 This number represents shares of Class A Common Stock sold to satisfy the tax withholding obligation due upon vesting of LSUs.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.95 to $34.93, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.975 to $35.060, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.35 to $34.92, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F7 LSUs vested on March 3, 2023.
F8 These LSUs do not expire.